If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
The Patient Capital Review was announced by the Prime Minister in November 2016. The review, which was led by HM Treasury, identified barriers to access to long-term finance for growing firms.
The terms of reference set out that the review would:
consider the availability of long-term finance for growing innovative firms looking to scale up
identify the long-term root causes affecting the availability of long-term finance for growing innovative firms, including any barriers that investors may face in providing long-term finance
review international best practices to inform recommendations for the UK market
consider the role of market practice and market norms in facilitating investment in long-term finance
assess what changes in government policy, if any, are needed to support the expansion of long-term capital for growing innovative firms
This independent review, produced by a separate industry panel chaired by Sir Damon Buffini, outlines the key themes for the review’s consultation phase and provides a package of recommendations as part of a formal response to the review’s consultation, which have now been published. The members of the industry panel were: